DAVID MEEKS EICH, MD
Osteopathic Medicine at Meade Pkwy, Suffolk, VA
License number
Virginia 0101-038618
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2000 Meade Pkwy, Suffolk, VA 23434
Phone
(757) 925-0759
(757) 934-9377 (Fax)
(757) 934-9377 (Fax)
Personal information
See more information about DAVID MEEKS EICH at radaris.comName
Address
Phone
1521 Pine Grove Ln, Chesapeake, VA 23321
919 Church St, Smithfield, VA 23430
6540 Ferry Point Rd, Suffolk, VA 23432
4868 Bridge Rd, Suffolk, VA 23435
4868 Bndge, Suffolk, VA 23432
Professional information
See more information about DAVID MEEKS EICH at trustoria.com
Dr. David M Eich - MD (Doctor of Medicine)
Dr. David M Eich - MD (Doctor of Medicine)
Hospitals:
Cardiology Associates Lakeview
3920A Bridge Rd SUITE 207, Suffolk 23435
Sentara Norfolk General Hospital
600 Gresham Dr, Norfolk 23507
Sentara Obici Hospital
2800 Godwin Blvd, Suffolk 23434
Cardiology Associates Lakeview
3920A Bridge Rd SUITE 207, Suffolk 23435
Sentara Norfolk General Hospital
600 Gresham Dr, Norfolk 23507
Sentara Obici Hospital
2800 Godwin Blvd, Suffolk 23434
3920A Bridge Rd SUITE 207, Suffolk 23435
Sentara Norfolk General Hospital
600 Gresham Dr, Norfolk 23507
Sentara Obici Hospital
2800 Godwin Blvd, Suffolk 23434
Cardiology Associates Lakeview
3920A Bridge Rd SUITE 207, Suffolk 23435
Sentara Norfolk General Hospital
600 Gresham Dr, Norfolk 23507
Sentara Obici Hospital
2800 Godwin Blvd, Suffolk 23434
Education:
Medical Schools
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1984
Virginia Commonwealth University / Medical College of Virginia School of Medicine
Graduated: 1984
David Meeks Eich, Suffolk VA
David Meeks Eich, Suffolk VA
Specialties:
Cardiologist
Address:
2000 Meade Pkwy, Suffolk, VA 23434
Education:
Medical College of Virginia - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Cardiovascular Disease (Internal Medicine), American Board of Internal Medicine Sub-certificate in Interventional Cardiology (Internal Medicine)
David M Eich, Suffolk VA
David M Eich, Suffolk VA
Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology, Interventional Cardiology
Work:
Sentara Cardiology Specialists
2000 Meade Pkwy, Suffolk, VA 23434 Sentara Cardiology Specialists
20209 Sentara Way, Carrollton, VA 23314 Virginia Health Network, Inc
600 Gresham Dr, Norfolk, VA 23507 Lakeview Medical Center
3920 Bridge Rd, Suffolk, VA 23435 Lakeview Medical Ctr
4868 Bridge Rd, Suffolk, VA 23435 Lakeview Medical Center
1301 Armory Dr, Franklin, VA 23851
2000 Meade Pkwy, Suffolk, VA 23434 Sentara Cardiology Specialists
20209 Sentara Way, Carrollton, VA 23314 Virginia Health Network, Inc
600 Gresham Dr, Norfolk, VA 23507 Lakeview Medical Center
3920 Bridge Rd, Suffolk, VA 23435 Lakeview Medical Ctr
4868 Bridge Rd, Suffolk, VA 23435 Lakeview Medical Center
1301 Armory Dr, Franklin, VA 23851
Education:
Virginia Commonwealth University (1984)
Method Of Using Dehydroepiandrosterone And Dehydroepiandrosterone-Sulfate As Inhibitors Of Platelet Aggregation
Method Of Using Dehydroepiandrosterone And Dehydroepiandrosterone-Sulfate As Inhibitors Of Platelet Aggregation
US Patent:
5110810, May 5, 1992
Filed:
Feb 8, 1991
Appl. No.:
7/652518
Inventors:
David M. Eich - Suffolk VA
Robert Jesse - Richmond VA
John Nestler - Richmond VA
Robert Jesse - Richmond VA
John Nestler - Richmond VA
Assignee:
Virginia Commonwealth University - Richmond VA
International Classification:
A61K 3156
US Classification:
514178
Abstract:
Treating human beings with pharmacological quantities of DHEA results in their blood having increased serum DHEA and DHEA-S and lower rates of platelet aggregation. Reducing the rate of platelet aggregation can significantly reduce the incidence or morbidity and mortality from vascular events such as myocardial infarction and stroke, as well as reduce the occurrence of restenosis following vascular interventions. The concentration of DHEA and DHEA-S in the blood and the pre-incubation time of DHEA and DHEA-S with the blood will affect its impact on platelet aggregation. Hence, prior treatment of patients who are at risk with DHEA may produce the most beneficial affects. In addition, treatment of blood with DHEA-S reduces thromboxane production. Thromboxane is produced after platelets are subjected to many different types of agonists and is responsible for recruiting other platelets to aggregate and form a thrombus; therefore, blocking the production of thromboxane will reduce or prevent platelet aggregation.